Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 303
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01243398	Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy	completed	Phase 3	450	University of OxfordOTHER	1	Nov 29, 2012	clinicaltrials
NCT00665197	Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia	completed	Phase 3	200	International Atomic Energy AgencyOTHER_GOV	7	Oct 13, 2011	clinicaltrials